NanoViricides
NNVC
47 hedge funds and large institutions have $3.27M invested in NanoViricides in 2026 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 9 closing their positions.
198% more capital inflows, than outflows
Capital inflows: $1.06M | Capital outflows: $356K
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
1.52% more ownership
Funds ownership: 8.8% → 10.32% (+1.5%)
2% less funds holding
Funds holding: 48 → 47 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$559K |
| 2 |
CCM
Connective Capital Management
Palo Alto,
California
|
+$254K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$119K |
| 4 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
+$57.4K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$156K |
| 2 |
Squarepoint
New York
|
-$53K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$52.7K |
| 4 |
XTX Topco
George Town,
Cayman Islands
|
-$32.3K |
| 5 |
Jane Street
New York
|
-$21.7K |
NNVC Hedge Fund Activity: Q2 2026 in Review
47 of the 8,353 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2026, worth a combined $3.27M — up 89% from $1.73M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of NNVC and 8 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 9 added.
The largest buyer was Vanguard Capital Management, adding an estimated $559K. The largest seller was UBS Group, cutting an estimated $156K.
- 47 institutional investors held NanoViricides (NNVC) as of Q2 2026, down from 48 in Q1 2026.
- Funds reported $3.27M of NanoViricides stock for Q2 2026, up 89% quarter-over-quarter.
- 8 funds opened new NanoViricides positions in Q2 2026 and 9 closed out, a net change of -1 holder.
- The largest NanoViricides buyer in Q2 2026 was Vanguard Capital Management, an estimated $559K added.
- The largest NanoViricides seller in Q2 2026 was UBS Group, an estimated $156K sold.
Based on aggregated 13F filings for Q2 2026.